Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole

Posaconazole is a triazole antifungal agent that has broad-spectrum activity against many yeasts and filamentous fungi, including Candida species, Cryptococcus neoformans, Aspergillus species, and Zygomycetes. This drug has been approved for the prevention of invasive fungal infections in patients w...

Descripción completa

Detalles Bibliográficos
Autor principal: Soysal, Ahmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573198/
https://www.ncbi.nlm.nih.gov/pubmed/26392781
http://dx.doi.org/10.2147/IDR.S65592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573198/
https://www.ncbi.nlm.nih.gov/pubmed/26392781
http://dx.doi.org/10.2147/IDR.S65592

Ejemplares similares